There is an increasing frequency of large wildfires in California. Smoke from these wildfires can drastically increase short-term exposure to harmful air pollutants, especially particulate matter (PM), and some KPNC members may be at greater risk of the a...
Funder: Northern California Community Benefit Programs
Investigator: Alexeeff, Stacey
|
This study is designed to help patients with type 2 diabetes and their clinicians identify which glucose-lowering medications among SGLT2 inhibitors, GLP-1 receptor agonists, DPP4 inhibitors, or Sulfonylureas have the most favorable effects on heart healt...
Funder: Patient-Centered Outcomes Research Institute
Investigator: Neugebauer, Romain
|
Chemotherapy-associated peripheral neuropathy (CPN) affects nearly 70% of cancer patients. An estimated 30% of cancer survivors have persistent CPN, which can have a devastating impact on their quality of life and functioning. Our objective is to develop ...
Funder: National Cancer Institute
Investigator: Neugebauer, Romain
|
This study develops generalized per-protocol analyses based on Inverse Probability Weighting and Targeted Learning to control for or evaluate the effect of medication nonadherence in observational studies that use electronic health databases to inform the...
Funder: Patient-Centered Outcomes Research Institute
Investigator: Neugebauer, Romain
|
Although there are marked ethnic disparities in rates of dementia, almost nothing is known about early-life contributors to dementia in ethnic minority groups, nor if the trajectory of cognitive decline or transition to cognitive impairment varies across ...
Funder: National Institute on Aging
Investigator: Quesenberry, Charles
|
Type 1 diabetes is a complicated disease requiring constant adherence to glycemic targets and meticulous attention and vigilance of blood sugar. Individuals with type 1 diabetes are living longer than ever before, yet very little is known about how this g...
Funder: National Institute on Aging
Investigator: Quesenberry, Charles
|
Rates of dementia and Alzheimer’s disease are 40% to 100% higher among African Americans compared to non-Hispanic whites. STAR is a longitudinal cohort study of lifecourse vascular risk and brain aging in 700 African Americans ages 50 and older. The goals...
Funder: National Institute on Aging
Investigator: Quesenberry, Charles
|
Alzheimer’s disease and other dementias affect 15 percent of those aged 65 and older, by age 90 and older this number increases to a startling 40 to 50 percent. The oldest-old, people aged 90 and older, are the fastest growing segment of the elderly popul...
Funder: National Institute on Aging
Investigator: Quesenberry, Charles
|
This is a retrospective cohort study of 5 million adult members of Kaiser Permanente Northern California during 2000 to 2012, linked to state-of-the-art estimates of exposure to PM2.5 (particulate matter less than 2.5 micrometers in diameter) generated at...
Funder: National Institute of Environmental Health Sciences
Investigator: Alexeeff, Stacey
|
Mini-Sentinel Task Order
Funder: U.S. Food and Drug Administration
Investigator: Fireman, Bruce
|
This study aims to evaluate the practicability and practical advantages of: 1) Targeted Minimum Loss based Estimation (TMLE), and 2) a high-dimensional propensity score (hdPS) algorithm to fit dynamic Marginal Structural Models (MSM) in a longitudinal com...
Funder: Agency for Healthcare Research and Quality
Investigator: Neugebauer, Romain
|
This project aims to develop SAS macros to automate the data structuring required for implementation of Causal Inference methods with electronic health records data in studies with time-varying exposures, confounding and selection bias (e.g., marginal str...
Funder:
Investigator: Neugebauer, Romain
|
Funder: U.S. Food and Drug Administration
Investigator: Fireman, Bruce
|
This study aims to strengthen causal inferences based on Marginal Structural Modeling (MSM) and large healthcare databases for Comparative Effectiveness Research in Type 2 Diabetes Mellitus (T2DM), specifically, it aims to: 1) Develop a consensus for the...
Funder: Patient-Centered Outcomes Research Institute
Investigator: Neugebauer, Romain
|